Stocktoria
Sartorius Aktiengesellschaft SRT.DE
Sartorius Aktiengesellschaft (SRT.DE) earns a Piotroski F-score of 8/9 (strong financial health). It pays a dividend yielding 0.39% (safety: safe). FY2025 revenue was €3.5B at a 4.4% net margin.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
How it ranks in Healthcare · percentile among 73 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 8/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
FAQ
Is SRT.DE financially healthy?
Sartorius Aktiengesellschaft's Piotroski F-score is 8/9 (8–9 is excellent, 0–3 weak).
Does SRT.DE pay a dividend, and is it safe?
Yes. Sartorius Aktiengesellschaft pays a dividend yielding about 0.39% with a 32.8% payout ratio, rated “safe” for safety.
How profitable is SRT.DE?
In FY2025, Sartorius Aktiengesellschaft had a net margin of 4.4% and a return on equity of 5.7%.
Computed from company filings · DE · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.